As this ICR is associated with the 45 day advance notice and call letter, which are both issued annually, this ICR is approved for 18 months. This ICR is approved on the understanding that, going forward, this ICR is related to the 45 day advance notice and call letter and that, as such, CMS agrees to sync up the public comment period for this ICR with the public comment period for the 45 day advance notice and the call letter. Even if CMS believes that the policies contained in the 45 day advance notice and call letter do not impact burden, the public shall be provided an opportunity to comment on CMS's burden assessment. To facilitate meaningful public comment, CMS agrees to reference this ICR by OMB control number in the 45 day advance notice and call letter, as appropriate. To the extent that changes in the 45 day advance notice and the call letter impact burden, the burden estimates in this ICR should be revised accordingly. Previous terms of clearance remain in effect.
Inventory as of this Action
Requested
Previously Approved
09/30/2010
36 Months From Approved
03/31/2011
6,050
0
6,050
42,350
0
42,350
0
0
0
Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), and implementing regulations at 42 CFR, Medicare Advantage organizations (MAO) and Prescription Drug Plans (PDP) are required to submit an actuarial pricing "bid" for each plan offered to Medicare beneficiaries for approval by the Centers for Medicare & Medicaid Services (CMS). MAOs and PDPs use the Bid Pricing Tool (BPT) software to develop their actuarial pricing bid. The information provided in the BPT is the basis for the plan's enrollee premiums and CMS payments for each contract year.
US Code:
42 USC 1395w-24
Name of Law: SUBMISSION OF PROPOSED PREMIUMS, BID AMOUNTS, AND RELATED INFORMATION
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
CMS-10142 Attachment C, CY2010 BPT changes PRA.pdf
2CY 2010 Bid Pricing Tool (BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans (PDP)-CMS-10142